CECCARINI, LUISA
CECCARINI, LUISA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
An automated docking protocol for HERG channel blockers.
2013 Di Martino G. P.; Masetti M.; Ceccarini L.; Cavalli A.; Recanatini M.
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities
2010 Bolognesi ML; Bartolini M ; Mancini F ; Chiriano G ; Ceccarini L; Rosini M; Milelli A; Tumiatti V; Andrisano V; Melchiorre C
Computational design and discovery of "minimally structured" hERG blockers.
2012 Cavalli A.; Buonfiglio R.; Ianni C.; Masetti M.; Ceccarini L.; Caves R.; Chang M.W.; Mitcheson J.S.; Roberti M.; Recanatini M.
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation
2009 Raschi E.; Ceccarini L.; De Ponti F.; Recanatini M.
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush
2008 M. Rosini; E. Simoni; M. Bartolini; A. Cavalli; L. Ceccarini; N. Pascu; D. W. McClymont; A. Tarozzi; M. L. Bolognesi; A. Minarini; V. Tumiatti; V. Andrisano; I. R. Mellor; C. Melchiorre
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities
2010 ML Bolognesi; M. Bartolini; F. Mancini; G. Chiriano; L. Ceccarini; M. Rosini; A. Milelli; V. Tumiatti; V. Andrisano; C. Melchiorre
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine
2008 S. Rizzo; A. Cavalli; L. Ceccarini; F. Belluti; A. Bisi; M. Bartolini; V. Andrisano; M. Recanatini; A. Rampa
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine
2009 S. Rizzo; A. Cavalli; L. Ceccarini; M. Bartolini; F. Belluti; A. Bisi; V. Andrisano; M. Recanatini; A. Rampa
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238
2010 S. Rizzo; M. Bartolini; L. Ceccarini; L. Piazzi ; S. Gobbi; A. Cavalli; M. Recanatini; V. Andrisano; A. Rampa
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| An automated docking protocol for HERG channel blockers. | Di Martino G. P.; Masetti M.; Ceccarini L.; Cavalli A.; Recanatini M. | 2013-01-01 | JOURNAL OF CHEMICAL INFORMATION AND MODELING | - | 1.01 Articolo in rivista | - |
| Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities | Bolognesi ML; Bartolini M ; Mancini F ; Chiriano G ; Ceccarini L; Rosini M; Milelli A; Tumiatti V...; Andrisano V; Melchiorre C | 2010-01-01 | CHEMMEDCHEM | - | 1.01 Articolo in rivista | - |
| Computational design and discovery of "minimally structured" hERG blockers. | Cavalli A.; Buonfiglio R.; Ianni C.; Masetti M.; Ceccarini L.; Caves R.; Chang M.W.; Mitcheson J....S.; Roberti M.; Recanatini M. | 2012-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| hERG-related drug toxicity and models for predicting hERG liability and QT prolongation | Raschi E.; Ceccarini L.; De Ponti F.; Recanatini M. | 2009-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.01 Articolo in rivista | - |
| Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush | M. Rosini; E. Simoni; M. Bartolini; A. Cavalli; L. Ceccarini; N. Pascu; D. W. McClymont; A. Taroz...zi; M. L. Bolognesi; A. Minarini; V. Tumiatti; V. Andrisano; I. R. Mellor; C. Melchiorre | 2008-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities | ML Bolognesi; M. Bartolini; F. Mancini; G. Chiriano; L. Ceccarini; M. Rosini; A. Milelli; V. Tumi...atti; V. Andrisano; C. Melchiorre | 2010-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine | S. Rizzo; A. Cavalli; L. Ceccarini; F. Belluti; A. Bisi; M. Bartolini; V. Andrisano; M. Recanatin...i; A. Rampa | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine | S. Rizzo; A. Cavalli; L. Ceccarini; M. Bartolini; F. Belluti; A. Bisi; V. Andrisano; M. Recanatin...i; A. Rampa | 2009-01-01 | CHEMMEDCHEM | - | 1.01 Articolo in rivista | - |
| Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 | S. Rizzo; M. Bartolini; L. Ceccarini; L. Piazzi ; S. Gobbi; A. Cavalli; M. Recanatini; V. Andrisa...no; A. Rampa | 2010-01-01 | BIOORGANIC & MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |